256 related articles for article (PubMed ID: 17875775)
1. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.
Zhong H; Han B; Tourkova IL; Lokshin A; Rosenbloom A; Shurin MR; Shurin GV
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5455-62. PubMed ID: 17875775
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (Paclitaxel) for murine fibrosarcoma.
Choi GS; Lee MH; Kim SK; Kim CS; Lee HS; Im MW; Kil HY; Seong DH; Lee JR; Kim WC; Lee MG; Song SU
Yonsei Med J; 2005 Dec; 46(6):835-42. PubMed ID: 16385661
[TBL] [Abstract][Full Text] [Related]
6. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
Liu Z; Fan H; Wu Y; Chen B
Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.
Teitz-Tennenbaum S; Li Q; Davis MA; Wilder-Romans K; Hoff J; Li M; Chang AE
J Immunother; 2009; 32(6):602-12. PubMed ID: 19483649
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of intratumoral administration of dendritic cell combination with vincristine chemotherapy in a murine fibrosarcoma model.
Shin JY; Lee SK; Kang CD; Chung JS; Lee EY; Seo SY; Lee SY; Baek SY; Kim BS; Kim JB; Yoon S
Histol Histopathol; 2003 Apr; 18(2):435-47. PubMed ID: 12647794
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
10. Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
Zhong H; Gutkin DW; Han B; Ma Y; Keskinov AA; Shurin MR; Shurin GV
Int J Cancer; 2014 Jun; 134(11):2633-45. PubMed ID: 24443321
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
Miller PW; Sharma S; Stolina M; Butterfield LH; Luo J; Lin Y; Dohadwala M; Batra RK; Wu L; Economou JS; Dubinett SM
Hum Gene Ther; 2000 Jan; 11(1):53-65. PubMed ID: 10646639
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
13. Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
He Q; Li J; Yin W; Song Z; Zhang Z; Yi T; Tang J; Wu D; Lu Y; Wang Z; Liu D; Zhang X; Hu Z; Gao J
Cancer Immunol Immunother; 2011 May; 60(5):715-30. PubMed ID: 21331814
[TBL] [Abstract][Full Text] [Related]
14. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
[TBL] [Abstract][Full Text] [Related]
15. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
16. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
17. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of dendritic cell loaded ex vivo and in vivo with tumor-associated antigens in lung cancer model.
Son CH; Bae JH; Shin DY; Lee HR; Yang K; Park YS
Immunol Invest; 2014; 43(5):447-62. PubMed ID: 24654594
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.
Huang X; Huang G; Song H; Chen L
Int J Cancer; 2011 Aug; 129(3):648-58. PubMed ID: 20878978
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.
Moyer JS; Li J; Wei S; Teitz-Tennenbaum S; Chang AE
J Immunother; 2008; 31(9):885-95. PubMed ID: 18832999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
